STAT

DECEMBER 23, 2023

STAT now publishes selected Letters to the Editor received in response to First Opinion essays to encourage robust, good-faith discussion about difficult issues. Submit a Letter to the Editor  here , or find the submission form at the end of any First Opinion essay.

FDA 102

FDA 102

pharmaphorum

DECEMBER 23, 2023

BMS has reached a $14bn agreement to buy Karuna and its KarXT schizophrenia candidate, due for an FDA verdict next September

FDA 105

FDA 105

Pharmacy Times

DECEMBER 23, 2023

From newsworthy moments to groundbreaking research, these were the most-read respiratory syncytial virus-related articles on Pharmacy Times in 2023.

65

65

Pharmacy Times

DECEMBER 23, 2023

From newsworthy moments to groundbreaking research, these were the most-read community pharmacy-related articles from Pharmacy Times in 2023.

Community Pharmacies 65

Community Pharmacies 65

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.